Your browser is no longer supported. Please, upgrade your browser.
STJ St. Jude Medical Inc. daily Stock Chart
St. Jude Medical Inc.
IndexS&P 500 P/E34.58 EPS (ttm)2.30 Insider Own0.10% Shs Outstand284.93M Perf Week0.57%
Market Cap22.69B Forward P/E18.02 EPS next Y4.42 Insider Trans0.00% Shs Float277.96M Perf Month-2.74%
Income661.00M PEG3.04 EPS next Q1.01 Inst Own83.40% Short Float3.52% Perf Quarter4.01%
Sales5.80B P/S3.92 EPS this Y-11.10% Inst Trans-2.67% Short Ratio3.16 Perf Half Y47.87%
Book/sh15.06 P/B5.29 EPS next Y8.95% ROA5.40% Target Price79.70 Perf Year22.28%
Cash/sh1.40 P/C57.01 EPS next 5Y11.38% ROE16.10% 52W Range48.35 - 84.00 Perf YTD30.20%
Dividend1.24 P/FCF44.76 EPS past 5Y2.30% ROI9.30% 52W High-5.19% Beta1.16
Dividend %1.56% Quick Ratio1.20 Sales past 5Y1.40% Gross Margin67.10% 52W Low64.70% ATR1.03
Employees18000 Current Ratio1.70 Sales Q/Q10.80% Oper. Margin16.10% RSI (14)50.13 Volatility0.79% 1.70%
OptionableYes Debt/Eq1.42 EPS Q/Q-18.70% Profit Margin11.40% Rel Volume0.38 Prev Close79.61
ShortableYes LT Debt/Eq1.27 EarningsOct 19 BMO Payout51.40% Avg Volume3.10M Price79.64
Recom3.00 SMA201.26% SMA50-1.71% SMA20017.49% Volume1,174,683 Change0.04%
Jul-21-16Reiterated Barclays Equal Weight $80 → $83
Jul-15-16Downgrade Wedbush Outperform → Neutral $70 → $84
Jul-11-16Downgrade Leerink Partners Outperform → Mkt Perform
May-10-16Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
May-03-16Downgrade Credit Suisse Outperform → Neutral
May-02-16Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-29-16Downgrade Needham Buy → Hold
Apr-28-16Downgrade Piper Jaffray Overweight → Neutral
Mar-17-16Initiated Nomura Buy
Feb-08-16Upgrade Canaccord Genuity Sell → Hold $54
Jan-28-16Reiterated Oppenheimer Perform $72 → $64
Jan-25-16Reiterated RBC Capital Mkts Sector Perform $66 → $57
Jan-19-16Downgrade Wells Fargo Outperform → Market Perform
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy
Oct-22-15Reiterated RBC Capital Mkts Sector Perform $75 → $66
Oct-22-15Downgrade Stifel Buy → Hold
Jul-23-15Reiterated Stifel Buy $81 → $89
Jul-23-15Reiterated RBC Capital Mkts Sector Perform $71 → $75
Jul-23-15Reiterated Barclays Overweight $84 → $86
Jul-23-15Downgrade Deutsche Bank Buy → Hold $76 → $77
Sep-23-16 05:07PM  The Rationale behind Johnson & Johnsons Acquisition of Abbott Medical Optics
Sep-19-16 05:35PM  Abbott Laboratories -- Moody's expectations for Abbott's ratings unchanged following news of medical optics sale at Moody's
11:04AM  St. Jude Medicals Stock Prices Are on a Declining Trend
10:04AM  Discussing St. Jude Medicals Latest Valuation
08:16AM  J&J (JNJ) to Buy Abbott's Vision Care Unit for $4.3 Billion
08:05AM  Most Analysts Rate St. Jude Medical a Hold
Sep-16-16 05:43PM  Abbott to sell its eye care business to J&J for about $4.33 bln
05:04PM  Analyzing St. Jude Medicals Latest Dividend Payment
03:04PM  Trial Progression of St. Jude Medicals Stroke Prevention Device
01:30PM  This Advisory Firms Name Held True to Form for St. Jude Medical
Sep-12-16 09:30AM  Can Abbott Labs Find a Cure for Its Ailing Shares?
Sep-09-16 06:04PM  New Long-Term Data Reaffirm the Benefits of Medtronics Micra TPS
Sep-07-16 07:06PM  St. Jude's lawsuit against short-seller faces steep climb -lawyers Reuters
04:27PM  St. Jude sues short-seller over heart device allegations Reuters
02:30PM  Reaction to St. Jude Cybersecurity Threat May Be Overdone
10:46AM  [$$] St Jude Medical sues Muddy Waters over hacking claims at Financial Times
10:29AM  [$$] St. Jude Medical Sues Muddy Waters at The Wall Street Journal
08:15AM  How Will St. Jude Medical (STJ) Stock React to Filing Lawsuit Against Muddy Waters, MedSec?
08:14AM  St. Jude sues Muddy Waters, MedSec over heart device allegations
07:57AM  St. Jude Medical Files Lawsuit Against Muddy Waters
07:43AM  St. Jude Medical Brings Legal Action Against Muddy Waters and MedSec Business Wire
Sep-06-16 06:33PM  Betting Against Stocks: Muddy Waters' St. Jude Short
Sep-02-16 09:54AM  St. Jude Medical (STJ) Launches Trial for Amulet Occluder
04:28AM  [$$] Gifts for Muddy Waters - the shouty short selling activist at Financial Times
Sep-01-16 04:42PM  Alere Asks for September Trial in Case Against Abbott
09:00AM  St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation Business Wire
08:05AM  EW Poised to Carve Out More Prosthetic Heart Valve Market Share
08:04AM  A Look at How C.R. Bards Valuation Compares to Its Peers
08:04AM  Medtronics Latest Valuation: Heres What You Need to Know
Aug-31-16 05:04PM  Edwards Lifesciences Capitalizes on Valve Replacement Market
03:04PM  What Caused Edwards Lifesciences to Guide Higher?
12:34PM  Analysts Recommendations for C.R. Bard in 2016
10:04AM  How Much Has Medtronic Returned to Shareholders in 1Q17?
Aug-30-16 02:37PM  University study finds flaws in criticism of St. Jude cyber security
11:03AM  St. Jude Medical (STJ) Stock Lower, Refutes Allegations Made by Muddy Waters
09:19AM  Post Earnings Coverage as Medtronic Earnings Surge 13 Percent on Lower Tax Bill
08:30AM  St. Jude Medical Continues to Refute Allegations made by Muddy Waters Capital and MedSec Business Wire
08:05AM  Analyzing Medtronics Sales Growth by Segment in 1Q17
Aug-29-16 05:07PM  Muddy Waters Short Seller Carson Block Takes on St. Jude at Investopedia
01:10PM  An Outside View on St. Jude Device Cyberattack Woes at 24/7 Wall St.
12:06PM  ETFs with exposure to St. Jude Medical, Inc. : August 29, 2016
Aug-26-16 06:38PM  Whiplashed investors stay skittish about St. Jude Reuters
05:26PM  [$$] St. Jude Denies Claims in Muddy Waters Report at The Wall Street Journal
04:43PM  St. Jude (STJ) Faces Long-Term Risks, Muddy Waters' Block Tells CNBC
04:24PM  St. Jude Medical Rejects Short-Sellers Allegations
04:21PM  Muddy Waters' Carson Block says St. Jude Medical shares could fall to $55 at CNBC
04:17PM  Shares of St. Jude Medical resume trading, recover losses at CNBC
03:43PM  St. Jude reopens
03:35PM  St. Jude Medical Refutes Muddy Waters Device Security Allegations and Reinforces Security of Devices and Commitment to Patient Safety Business Wire
03:30PM  St. Jude (STJ) Stock Down Despite Response to Muddy Waters Allegations
03:06PM  St. Jude halted for news
10:47AM  St. Jude Medical (STJ) Stock Down, Credit Suisse: Shares Likely to Remain Pressured
08:17AM  Early movers: HLF, AAPL, TSLA, SCTY, VIAB, PSTG & more at CNBC
08:12AM  St. Jude Medical, Inc. breached its 50 day moving average in a Bearish Manner : STJ-US : August 26, 2016
Aug-25-16 07:47PM  [$$] Muddy Waters-St Jude: heart attack at Financial Times
04:55PM  Medtronic Misses High Expectations; St. Jude Dives On Hacking Claim
04:49PM  Pitts: Carson Block's St. Jude Comments Are a Market Play
04:43PM  St. Jude Medical drops after Muddy Water findings of 'negligent product design' at CNBC
03:59PM  MedSec CEO Responds to Carson Block's St. Jude Comments
02:05PM  St. Jude devices are easy targets for hackers, short-seller says (Video) at
12:52PM  Will MedSec's St.Jude Claims Impact Abbott Deal?
12:35PM  MedSec's Bone: Hope St. Jude Responds With Urgency
12:31PM  Bone: St. Jude Has History of Sweeping Things Under Table
12:13PM  Markets React to Muddy Waters Short of St. Jude
12:06PM  St. Jude: Several Layers of Security in Place
12:00PM  St. Jude (STJ) Stock Drops, Muddy Waters Shorts on Security Flaw
11:27AM  St. Jude Medical's stock drops after short seller Muddy Waters takes aim at MarketWatch
11:01AM  Block Bets St. Jude Security Flaw Will Derail Abbott Deal
10:58AM  Carson Block Shorts St. Jude on Hack Threat
Aug-24-16 05:50PM  Top 10 Stocks Hedge Funds Bought and Sold in Q2 (HOT, STJ) at Investopedia
08:41AM  Medtronic Earnings Face FX Headwinds, But Cardiac Trends Good
Aug-22-16 11:00AM  Kessler Topaz Meltzer & Check, LLP and Motley Rice LLC Announce Proposed Settlement of Class Action Lawsuit Involving Purchasers of St. Jude Medical, Inc. Common Stock PR Newswire
Aug-18-16 04:30PM  A Look at Boston Scientifics Latest Valuation
04:05PM  John Rogers Comments on Abbott Laboratories
Aug-15-16 04:25PM  Hedge funds made big changes at drug companies in 2nd qtr -filings
Aug-12-16 12:41PM  Barclays Says Investors Underestimate St. Jude Medical 's Potential
Aug-10-16 01:04PM  ST JUDE MEDICAL INC Financials
Aug-08-16 02:44PM  ETFs with exposure to St. Jude Medical, Inc. : August 8, 2016
Aug-03-16 04:25PM  ST JUDE MEDICAL INC Files SEC form 10-Q, Quarterly Report
04:15PM  St. Jude Medical Announces Third Quarter Dividend Business Wire
01:51AM  St. Jamess Place Plc :STJ-GB: Earnings Analysis: For the six months ended June 30, 2016 : August 3, 2016
Jul-29-16 12:58PM  Boston Scientifics Stock Surged after 2Q16 Earnings
11:17AM  C.R. Bards Vascular Segment Flowing Well despite Tougher Comps
11:17AM  C.R. Bard Registered Strong 2Q16 Performance, Beat Estimates
06:38AM  Did Baxter International Beat 2Q16 Earnings Estimates?
Jul-22-16 05:22PM  Johnson & Johnson Reports 4% Sales Growth for the Second Quarter
03:25PM  ETFs with exposure to St. Jude Medical, Inc. : July 22, 2016
01:28PM  St. Jude Medical Gets Hold Rating from 96% of Analysts
01:28PM  How St. Jude Medical Beat 2Q16 Wall Street Estimates
08:55AM  Did Hedge Funds Anticipate These M&A Deals? at Insider Monkey
07:29AM  R&D Investments, Product Launches Key to Abbotts 2Q Performance
Jul-21-16 11:34AM  St. Jude Medical, Inc. :STJ-US: Earnings Analysis: Q2, 2016 By the Numbers : July 21, 2016
06:05AM  A Look at Ingersoll Rand Stock ahead of 2Q16 Earnings
Jul-20-16 05:16PM  WeissLaw LLP Files Class Action Lawsuit Against St. Jude Medical, Inc. PR Newswire
03:06PM  [$$] Abbott Labs Profit Tops Views at The Wall Street Journal
12:55PM  Abbott's Alere Deal Continues To Face Uncertainty
12:15PM  Edited Transcript of STJ earnings conference call or presentation 20-Jul-16 12:00pm GMT
11:41AM  St. Jude Medical, Stepan Company & Three Other Stocks Trending on Strong Quarterly Results at Insider Monkey
10:40AM  [$$] St. Jude Medical Logs Double-Digit Sales Growth at The Wall Street Journal
10:12AM  St. Jude Medical (STJ) Meets Q2 Earnings, Withdraws Outlook
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers tachycardia implantable cardioverter defibrillator systems and cardiac resynchronization therapy defibrillator devices to treat patients with tachycardia. It also provides atrial fibrillation products comprising electrophysiology, introducers and catheters, advanced cardiac mapping, navigation and recording systems, and ablation systems; and pacemakers, which deliver low-voltage electrical impulses to stimulate a heartbeat for patients whose hearts beat too slowly. In addition, the company offers vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, percutaneous catheter introducers, diagnostic guidewires, heart failure monitoring devices, renal denervation technology and vascular plugs, optical coherence tomography imaging products, and other vascular accessories, as well as CardioMEMS, a heart failure monitoring device. Further, it provides structural heart products, including heart valve replacement and repair products, and structural heart defect devices; neuromodulation products, such as spinal cord stimulation and radiofrequency ablation to treat chronic pain, as well as deep brain stimulation to treat movement disorders; and thoratec products comprising ventricular assist devices and percutaneous heart pumps. The company sells its products through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fecho JeffVP, Global QualityJan 27Option Exercise35.277,075249,5358,912Jan 29 04:51 PM
ROCCA MICHAEL ADirectorMay 03Option Exercise40.938,800360,18430,009May 05 04:09 PM
DEVENUTI RICHARD RDirectorMay 02Option Exercise40.938,800360,18439,630May 04 04:03 PM
ESSIG STUARTDirectorApr 22Option Exercise40.938,800360,18445,099Apr 26 04:25 PM
Fecho JeffVP, Global QualityFeb 05Option Exercise35.1710,408366,05712,816Feb 09 04:17 PM
Fecho JeffVP, Global QualityFeb 05Sale51.7110,408538,1985,741Feb 09 04:17 PM
HILL BARBARA BDirectorFeb 03Option Exercise40.938,800360,18429,185Feb 05 04:24 PM
WIDENSOHLER STEFAN KDirectorFeb 01Option Exercise40.938,800360,18431,288Feb 03 04:35 PM
Zurbay DonaldVP Finance and CFODec 21Sale60.963,106189,34219,284Dec 22 04:00 PM
HEINMILLER JOHN CExecutive Vice PresidentDec 18Sale61.168,009489,830237,211Dec 22 04:01 PM
Thome ScottVP, Global Ops & Supply ChainNov 02Option Exercise41.652,999124,9083,354Nov 04 04:59 PM
Zellers JasonVP, General Counsel & Corp SecNov 02Option Exercise34.9613,333466,12223,388Nov 04 05:03 PM
Thome ScottVP, Global Ops & Supply ChainNov 02Sale64.354,595295,690355Nov 04 04:59 PM
Zellers JasonVP, General Counsel & Corp SecNov 02Sale64.2913,333857,17910,055Nov 04 05:03 PM
Zellers JasonVP, General Counsel & Corp SecOct 31Sale64.6629419,01010,055Nov 04 05:03 PM
STARKS DANIEL JChairman, CEO & PresidentOct 28Option Exercise40.55120,0004,866,0006,232,363Oct 30 04:31 PM
STARKS DANIEL JChairman, CEO & PresidentOct 28Sale62.36120,0007,483,3916,112,363Oct 30 04:31 PM
Fecho JeffVP, Global QualityOct 26Option Exercise44.6375033,4734,403Oct 28 04:31 PM
Fecho JeffVP, Global QualityOct 26Sale62.9075047,1753,653Oct 28 04:31 PM